Oncolytics Biotech
ONCY
#9647
Rank
C$0.13 B
Marketcap
C$1.16
Share price
-3.60%
Change (1 day)
-31.01%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of March 2026 : C$0.71 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is C$0.71 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.77 M-29.4%
2024-12-31C$1.09 M158.21%
2023-12-31C$0.42 M13.4%
2022-12-31C$0.37 M-43.04%
2021-12-31C$0.65 M62.85%
2020-12-31C$0.4 M-20.58%
2019-12-31C$0.5 M
2018-12-31N/A
2006-12-31C$0.14 M-0.36%
2005-12-31C$0.15 M0.33%
2004-12-31C$0.14 M-0.12%
2003-12-31C$0.15 M-0.29%
2002-12-31C$0.15 M0.26%
2001-12-31C$0.15 M0.15%
2000-12-31C$0.14 M0.33%
1999-12-31C$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
C$60.97 B 8,537,301.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$65.27 B 9,139,270.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
C$70.61 M 9,786.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
C$2.37 M 232.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.77 B 3,328,049.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
C$54.38 M 7,514.17%๐Ÿ‡บ๐Ÿ‡ธ USA